Nihal Turkmen Alemdar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nihal Turkmen Alemdar has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Selim Demir
Department of Medical Biochemistry, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkiye
28 shared publications - Ahmet Mentese
Department of Medical Biochemistry, Faculty of Medicine, Karadeniz Technical University, Trabzon 61080, Türkiye
24 shared publications - Yuksel Aliyazicioglu
Department of Medical Biochemistry, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkiye
23 shared publications - Elif Ayazoglu Demir
Department of Chemistry and Chemical Processing Technologies, Macka Vocational School, Karadeniz Technical University, Trabzon, Turkiye
22 shared publications - Esin Yulug
Department of Histology and Embryology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkiye
7 shared publications - Hatice Kucuk
Department of Pathology, Kanuni Training and Research Hospital, University of Health Sciences, Trabzon, Turkiye
6 shared publications
Latest Publications
- 16 October 2026
- Published by Akademiai Kiado Zrt. in Imaging
- Vol. 113 (3) , 457-472
Ferulic acid abrogates methotrexate-induced pulmonary injury by reducing inflammation and endoplasmic reticulum stress in rats
Background: The methotrexate (MTX) is employed in the treatment of various malignancies, including breast cancer and lymphoma, as well as chronic inflammatory diseases, but high doses can cause pulmonotoxicity. Ferulic acid (FEA) is a phenolic compound that has become a promising candidate for oxidative stress (OS) related diseases over the past few years because of its striking range of biological activities. The aim of this experimental study was to investigate the protective effects of FEA against MTX-induced pulmonary toxicity via the potential mechanisms of OS, inflammation, endoplasmic reticulum stress (ERS) and sirtuin 1 (SIRT1)/nuclear factor erythroid 2-related factor 2 (Nrf2) signalling. Methods: The rats were administered FEA (50 and 100 mg kg −1 , p.o.) on consecutive days for a period of seven days. Meanwhile, MTX (20 mg kg −1 , i.p.) was administered as a single injection on the second day of the study. At the conclusion of the treatment period, samples of lung tissue were examined in terms of histopathological findings, while the remaining tissue samples were evaluated in terms of OS, inflammation, ERS, SIRT1/Nrf2 pathway and apoptosis for further colorimetric analysis. Results: The administration of MTX suppressed the SIRT1/Nrf2 signalling pathway, resulting in histopathological findings characterised by a dramatic increase in OS, inflammation and ERS levels in the lung tissue. However, the FEA treatments attenuated these harmful effects by modulating the SIRT1/Nrf2 signalling pathway. Conclusion: Taken together, these results suggest that FEA may be protective against MTX-induced pulmonary toxicity. Nevertheless, further studies are required to elucidate the precise mechanisms of the protective effects of FEA.
- 16 October 2026
- Published by Akademiai Kiado Zrt. in Imaging
- Vol. 113 (3) , 457-472
Ferulic acid abrogates methotrexate-induced pulmonary injury by reducing inflammation and endoplasmic reticulum stress in rats
Background: The methotrexate (MTX) is employed in the treatment of various malignancies, including breast cancer and lymphoma, as well as chronic inflammatory diseases, but high doses can cause pulmonotoxicity. Ferulic acid (FEA) is a phenolic compound that has become a promising candidate for oxidative stress (OS) related diseases over the past few years because of its striking range of biological activities. The aim of this experimental study was to investigate the protective effects of FEA against MTX-induced pulmonary toxicity via the potential mechanisms of OS, inflammation, endoplasmic reticulum stress (ERS) and sirtuin 1 (SIRT1)/nuclear factor erythroid 2-related factor 2 (Nrf2) signalling. Methods: The rats were administered FEA (50 and 100 mg kg −1 , p.o.) on consecutive days for a period of seven days. Meanwhile, MTX (20 mg kg −1 , i.p.) was administered as a single injection on the second day of the study. At the conclusion of the treatment period, samples of lung tissue were examined in terms of histopathological findings, while the remaining tissue samples were evaluated in terms of OS, inflammation, ERS, SIRT1/Nrf2 pathway and apoptosis for further colorimetric analysis. Results: The administration of MTX suppressed the SIRT1/Nrf2 signalling pathway, resulting in histopathological findings characterised by a dramatic increase in OS, inflammation and ERS levels in the lung tissue. However, the FEA treatments attenuated these harmful effects by modulating the SIRT1/Nrf2 signalling pathway. Conclusion: Taken together, these results suggest that FEA may be protective against MTX-induced pulmonary toxicity. Nevertheless, further studies are required to elucidate the precise mechanisms of the protective effects of FEA.
- Open Access
- 30 September 2026
- Published by Elsevier in Kuwait Journal of Science
- Vol. 54 (1)
Attenuation of cisplatin-induced oxidative ovarian injury by usnic acid in rats through inhibition of inflammation and endoplasmic reticulum stress
- 30 September 2026
- Published by Elsevier in Kuwait Journal of Science
- Vol. 54 (1)
Open AccessAttenuation of cisplatin-induced oxidative ovarian injury by usnic acid in rats through inhibition of inflammation and endoplasmic reticulum stress
- Open Access
Serum TLR4, NF-κB, and NLRP3 Levels in Children with Attention-Deficit/Hyperactivity Disorder: A Case–Control Study
Background: Increasing evidence suggests that inflammatory processes may be involved in the pathophysiology of attention-deficit/hyperactivity disorder (ADHD). However, clinical data regarding TLR4, NF-κB and NLRP3 in children with ADHD remain limited. This study aimed to compare serum TLR4, NF-κB, and NLRP3 levels between children with ADHD and healthy controls and to examine the associations between these inflammatory markers and ADHD symptom severity. Methods: A total of 42 children with ADHD and 40 age- and sex-matched healthy controls were enrolled. ADHD symptoms were assessed using the Conners’ Parent Rating Scale–Revised Short Form (CPRS-RS) and the Conners’ Teacher Rating Scale–Revised Short Form (CTRS-RS). Serum TLR4, NF-κB, and NLRP3 levels were measured using enzyme-linked immunosorbent assay (ELISA). Between-group comparisons were performed after adjustment for age, sex, and body mass index (BMI), and correlations between inflammatory markers and symptom severity were evaluated. Results: Serum NF-κB and NLRP3 levels were significantly higher in children with ADHD than in healthy controls, whereas serum TLR4 levels did not differ between groups. Serum NF-κB levels showed a moderate positive correlation with teacher-rated hyperactivity scores, while no significant associations were observed between TLR4 or NLRP3 levels and ADHD symptom severity in the ADHD group. Conclusions: Our findings provide preliminary clinical evidence of altered NF-κB and NLRP3 levels in children with ADHD. The absence of a significant difference in serum TLR4 levels, despite increased NF-κB and NLRP3 levels, suggests that these inflammatory components may be differentially altered in ADHD. Further longitudinal and mechanistic studies are needed to clarify the relevance of these inflammatory alterations to ADHD pathophysiology.
Open AccessSerum TLR4, NF-κB, and NLRP3 Levels in Children with Attention-Deficit/Hyperactivity Disorder: A Case–Control Study
Background: Increasing evidence suggests that inflammatory processes may be involved in the pathophysiology of attention-deficit/hyperactivity disorder (ADHD). However, clinical data regarding TLR4, NF-κB and NLRP3 in children with ADHD remain limited. This study aimed to compare serum TLR4, NF-κB, and NLRP3 levels between children with ADHD and healthy controls and to examine the associations between these inflammatory markers and ADHD symptom severity. Methods: A total of 42 children with ADHD and 40 age- and sex-matched healthy controls were enrolled. ADHD symptoms were assessed using the Conners’ Parent Rating Scale–Revised Short Form (CPRS-RS) and the Conners’ Teacher Rating Scale–Revised Short Form (CTRS-RS). Serum TLR4, NF-κB, and NLRP3 levels were measured using enzyme-linked immunosorbent assay (ELISA). Between-group comparisons were performed after adjustment for age, sex, and body mass index (BMI), and correlations between inflammatory markers and symptom severity were evaluated. Results: Serum NF-κB and NLRP3 levels were significantly higher in children with ADHD than in healthy controls, whereas serum TLR4 levels did not differ between groups. Serum NF-κB levels showed a moderate positive correlation with teacher-rated hyperactivity scores, while no significant associations were observed between TLR4 or NLRP3 levels and ADHD symptom severity in the ADHD group. Conclusions: Our findings provide preliminary clinical evidence of altered NF-κB and NLRP3 levels in children with ADHD. The absence of a significant difference in serum TLR4 levels, despite increased NF-κB and NLRP3 levels, suggests that these inflammatory components may be differentially altered in ADHD. Further longitudinal and mechanistic studies are needed to clarify the relevance of these inflammatory alterations to ADHD pathophysiology.
- Open Access
- 16 September 2026
- Published by Springer Nature in BMC Complementary Medicine and Therapies
Protocatechuic acid counteracts cisplatin-induced oxidative testicular injury in rats through modulation of redox homeostasis
- 16 September 2026
- Published by Springer Nature in BMC Complementary Medicine and Therapies
Open AccessProtocatechuic acid counteracts cisplatin-induced oxidative testicular injury in rats through modulation of redox homeostasis
- Open Access
- 16 March 2026
- Published by Wiley in Environmental Toxicology
- Vol. 41 (11) , 1416-1426
Chrysin Mitigates Acetamiprid‐Induced Testicular Injury in Mice via Suppression of Endoplasmic Reticulum Stress and Inflammation
Acetamiprid (ACP) is a neonicotinoid pesticide that is extensively utilized for the management of insect populations, but its toxic effects on the male reproductive system have become a source of concern. Chrysin (CHR) is a natural flavone found in many plants and bee products, including honey and propolis. The objective of this study was to evaluate the protective effect of CHR on ACP‐induced testicular injury in male Balb/c mice. ACP (20 mg/kg) and CHR applications (10 and 20 mg/kg, respectively) were conducted via intragastric route for a period of 14 days. The administration of CHR treatments resulted in a substantial improvement in oxidative stress and inflammation levels, achieved by the elimination of ACP's inhibition of the Nrf2 pathway. CHR treatments significantly reversed the ACP‐induced depletion in serum testosterone and inhibin B levels. Specifically, the treatment of CHR at a dose of 20 mg/kg resulted in a substantial improvement in degenerative testicular findings induced by ACP, as indicated by a significant reduction in TUNEL (+) cell count. Furthermore, the provision of CHR treatments resulted in the cessation of the decline in sperm count and viability that had been induced by ACP, whilst concomitantly leading to a substantial reduction in the number of spermatozoa that exhibited severe abnormalities. These results suggest that CHR may have a protective effect against ACP‐induced testicular damage; however, the results require further corroboration through the implementation of more comprehensive studies.
- 16 March 2026
- Published by Wiley in Environmental Toxicology
- Vol. 41 (11) , 1416-1426
Open AccessChrysin Mitigates Acetamiprid‐Induced Testicular Injury in Mice via Suppression of Endoplasmic Reticulum Stress and Inflammation
Acetamiprid (ACP) is a neonicotinoid pesticide that is extensively utilized for the management of insect populations, but its toxic effects on the male reproductive system have become a source of concern. Chrysin (CHR) is a natural flavone found in many plants and bee products, including honey and propolis. The objective of this study was to evaluate the protective effect of CHR on ACP‐induced testicular injury in male Balb/c mice. ACP (20 mg/kg) and CHR applications (10 and 20 mg/kg, respectively) were conducted via intragastric route for a period of 14 days. The administration of CHR treatments resulted in a substantial improvement in oxidative stress and inflammation levels, achieved by the elimination of ACP's inhibition of the Nrf2 pathway. CHR treatments significantly reversed the ACP‐induced depletion in serum testosterone and inhibin B levels. Specifically, the treatment of CHR at a dose of 20 mg/kg resulted in a substantial improvement in degenerative testicular findings induced by ACP, as indicated by a significant reduction in TUNEL (+) cell count. Furthermore, the provision of CHR treatments resulted in the cessation of the decline in sperm count and viability that had been induced by ACP, whilst concomitantly leading to a substantial reduction in the number of spermatozoa that exhibited severe abnormalities. These results suggest that CHR may have a protective effect against ACP‐induced testicular damage; however, the results require further corroboration through the implementation of more comprehensive studies.
- Open Access
- 6 June 2025
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 25 (1) , 1-12
Acetamiprid-induced testicular toxicity in mice: ameliorative effect and potential mechanisms of morin
Acetamiprid (ACP) is a novel chloronicotinyl insecticide that has been extensively utilized in agricultural, domestic, and public health contexts for nearly two decades. However, its potential to induce organ damage, including reproductive toxicity in mammals, has emerged as a significant concern. Morin is a naturally occurring flavonol that has gained prominence as a food supplement in recent years due to its antioxidant and anti-inflammatory properties. The objective of this study was to evaluate the protective effect of morin against testicular damage in mice subjected to ACP exposure. Thirty male Balb/c mice were randomly assigned to one of five groups, with the following treatment allocations: control, ACP (20 mg/kg), ACP + morin (15 and 30 mg/kg), and only morin (30 mg/kg). ACP and morin applications were conducted orally over a period of 14 days. Hormonal analyses were conducted on serum samples obtained from the mice, while biochemical and histological evaluations were performed on testicular samples. The biochemical results demonstrated that ACP elevated oxidative stress, inflammation, and ER stress in testicular tissue by inhibiting the Nrf2 pathway, a finding that was corroborated by histopathological analyses. However, morin treatments eliminated ACP-induced Nrf2 inhibition and to activate antioxidant and anti-inflammatory mechanisms. These findings were also corroborated by the restoration of serum testosterone and inhibin B levels and the diminution of histopathological lesions. Overall, the findings indicated that morin may have potential protective properties against ACP-associated reproductive toxicity, however, further research is required to determine the detailed molecular mechanisms.
- 6 June 2025
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 25 (1) , 1-12
Open AccessAcetamiprid-induced testicular toxicity in mice: ameliorative effect and potential mechanisms of morin
Acetamiprid (ACP) is a novel chloronicotinyl insecticide that has been extensively utilized in agricultural, domestic, and public health contexts for nearly two decades. However, its potential to induce organ damage, including reproductive toxicity in mammals, has emerged as a significant concern. Morin is a naturally occurring flavonol that has gained prominence as a food supplement in recent years due to its antioxidant and anti-inflammatory properties. The objective of this study was to evaluate the protective effect of morin against testicular damage in mice subjected to ACP exposure. Thirty male Balb/c mice were randomly assigned to one of five groups, with the following treatment allocations: control, ACP (20 mg/kg), ACP + morin (15 and 30 mg/kg), and only morin (30 mg/kg). ACP and morin applications were conducted orally over a period of 14 days. Hormonal analyses were conducted on serum samples obtained from the mice, while biochemical and histological evaluations were performed on testicular samples. The biochemical results demonstrated that ACP elevated oxidative stress, inflammation, and ER stress in testicular tissue by inhibiting the Nrf2 pathway, a finding that was corroborated by histopathological analyses. However, morin treatments eliminated ACP-induced Nrf2 inhibition and to activate antioxidant and anti-inflammatory mechanisms. These findings were also corroborated by the restoration of serum testosterone and inhibin B levels and the diminution of histopathological lesions. Overall, the findings indicated that morin may have potential protective properties against ACP-associated reproductive toxicity, however, further research is required to determine the detailed molecular mechanisms.
- Open Access
- 30 May 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (6) , 563
In Vitro Effects of Some Antibiotics on Purified β-Glucosidases from Rat Liver and Kidney Tissues
Background: Antibiotics are antimicrobial drugs used to treat and prevent infections. Unconscious use of antibiotics leads to many negative results. This study aimed to emphasize the negative aspects of antibiotics by determining their effects on purified enzymes. Methods: Beta glucosidase enzymes (BGLs) were purified from rat liver and kidney tissues using the sepharose-4B-LTyrosine-1-Naphthylamine hydrophobic interaction chromatography method. Liver BGL enzyme was purified 30.2-fold with a yield of 43.4%, while kidney BGL was purified 5.1-fold with a yield of 12.2%. Purified enzymes were visualized using SDS–PAGE. In vitro inhibition effects of ampicillin cefuroxime, amoxicillin–clavulanate, cefazolin sodium, gentamicin, and ceftriaxone antibiotics were determined on purified BGLs. Results: Ampicillin was found to inhibit rat liver and kidney BGLs competitively and uncompetitively, with IC50 values of 69.56 and 25.30 mM, respectively. Other antibiotics investigated did not significantly reduce liver BGL activity. Cefuroxime inhibited rat kidney BGL uncompetitively with IC50 values of 76.88 mM, while amoxicillin–clavulanate and cefazolin sodium inhibited it noncompetitively, with IC50 values of 41.32 and 98.81 mM, respectively. Gentamicin and ceftriaxone, whose effects were investigated, did not reduce kidney BGL activity. Conclusions: Some of the commonly used antibiotics reduce liver and kidney BGL activity, and this indicates that they may potentially impair metabolic functions. These results emphasize that caution should be exercised when using antibiotics.
- 30 May 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (6) , 563
Open AccessIn Vitro Effects of Some Antibiotics on Purified β-Glucosidases from Rat Liver and Kidney Tissues
Background: Antibiotics are antimicrobial drugs used to treat and prevent infections. Unconscious use of antibiotics leads to many negative results. This study aimed to emphasize the negative aspects of antibiotics by determining their effects on purified enzymes. Methods: Beta glucosidase enzymes (BGLs) were purified from rat liver and kidney tissues using the sepharose-4B-LTyrosine-1-Naphthylamine hydrophobic interaction chromatography method. Liver BGL enzyme was purified 30.2-fold with a yield of 43.4%, while kidney BGL was purified 5.1-fold with a yield of 12.2%. Purified enzymes were visualized using SDS–PAGE. In vitro inhibition effects of ampicillin cefuroxime, amoxicillin–clavulanate, cefazolin sodium, gentamicin, and ceftriaxone antibiotics were determined on purified BGLs. Results: Ampicillin was found to inhibit rat liver and kidney BGLs competitively and uncompetitively, with IC50 values of 69.56 and 25.30 mM, respectively. Other antibiotics investigated did not significantly reduce liver BGL activity. Cefuroxime inhibited rat kidney BGL uncompetitively with IC50 values of 76.88 mM, while amoxicillin–clavulanate and cefazolin sodium inhibited it noncompetitively, with IC50 values of 41.32 and 98.81 mM, respectively. Gentamicin and ceftriaxone, whose effects were investigated, did not reduce kidney BGL activity. Conclusions: Some of the commonly used antibiotics reduce liver and kidney BGL activity, and this indicates that they may potentially impair metabolic functions. These results emphasize that caution should be exercised when using antibiotics.
- 30 December 2024
- Published by Tıp Fakültesi, Karadeniz Teknik Üniversitesi in Farabi Tıp Dergisi
- Vol. 3 (4) , 119-125
Gallic Acid Alleviates Methotrexate‐Induced Oxidative Ovarian Damage in Rats
Although methotrexate (MTX) is an effective chemotherapeutic agent in the treatment of cancer, its use is limited due to the occurrence of systemic tissue toxicity, including those affecting the reproductive system. Gallic acid (GAL) is a phenolic compound that has been demonstrated to exert beneficial effects in a number of pathological conditions associated with oxidative stress (OS) in recent years. This study was designed to investigate the potential therapeutic benefits of GAL in the treatment of MTX-induced ovarian damage, for the first time. Adult female rats (n=30) were randomly allocated to five groups: control, MTX, MTX+GAL (2.5 and 5 mg/kg) and high-dose GAL only (5 mg/kg). A single intraperitoneal injection of MTX (20 mg/kg) was administered to induce ovarian toxicity. The treatment groups were administered 2.5 and 5 mg/kg of GAL intraperitoneally for a period of three consecutive days. The levels of OS, inflammation and apoptosis were determined in ovarian tissue samples collected on the fifth day of the study using spectrophotometric methods. The results showed that GAL treatment reduced the level of ovarian lipid peroxidation, inflammation, and apoptosis and promoted the ovarian antioxidant system in rats subjected to MTX. The results of this study indicate that GAL may have the potential to ameliorate MTX-associated oxidative and inflammatory ovarian damage. The ovarian protective effect of GAL requires further confirmation through more extensive preclinical studies.
- 30 December 2024
- Published by Tıp Fakültesi, Karadeniz Teknik Üniversitesi in Farabi Tıp Dergisi
- Vol. 3 (4) , 119-125
Gallic Acid Alleviates Methotrexate‐Induced Oxidative Ovarian Damage in Rats
Although methotrexate (MTX) is an effective chemotherapeutic agent in the treatment of cancer, its use is limited due to the occurrence of systemic tissue toxicity, including those affecting the reproductive system. Gallic acid (GAL) is a phenolic compound that has been demonstrated to exert beneficial effects in a number of pathological conditions associated with oxidative stress (OS) in recent years. This study was designed to investigate the potential therapeutic benefits of GAL in the treatment of MTX-induced ovarian damage, for the first time. Adult female rats (n=30) were randomly allocated to five groups: control, MTX, MTX+GAL (2.5 and 5 mg/kg) and high-dose GAL only (5 mg/kg). A single intraperitoneal injection of MTX (20 mg/kg) was administered to induce ovarian toxicity. The treatment groups were administered 2.5 and 5 mg/kg of GAL intraperitoneally for a period of three consecutive days. The levels of OS, inflammation and apoptosis were determined in ovarian tissue samples collected on the fifth day of the study using spectrophotometric methods. The results showed that GAL treatment reduced the level of ovarian lipid peroxidation, inflammation, and apoptosis and promoted the ovarian antioxidant system in rats subjected to MTX. The results of this study indicate that GAL may have the potential to ameliorate MTX-associated oxidative and inflammatory ovarian damage. The ovarian protective effect of GAL requires further confirmation through more extensive preclinical studies.